Results
|
|
1.
|
Obesity in adult lymphoma survivors. MedStar authors:
- Catlett, Joseph
- Lynce, Filipa
- Malkovska, Vera
- Pehlivanova, Marieta
Citation: - Leukemia & Lymphoma. 53(4):569-74, 2012 Apr.
Institution:
- MedStar Health Research Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Catlett J, Lynce F, Malkovska V, Pehlivanova M
|
|
|
2.
|
Misperception of body weight among overweight or obese adults in Mauritius. MedStar authors: - Echouffo-Tcheugui, Justin B
Year: 2016
Citation: - Obesity Research & Clinical Practice. 10(2):216-9, 2016 Mar-Apr
Institution: - MedStar Union Memorial Hospital
Department: - Medicine/Internal Medicine
Medline publication type:
All authors: - Caleyachetty R, Echouffo-Tcheugui JB, Kengne AP, Muennig P, Rutter H
|
|
|
3.
|
|
|
|
4.
|
Scout view X-ray attenuation versus weight-based selection of reduced peak tube voltage in cardiac CT angiography. MedStar authors:
- Ghafourian, Kambiz
- Simprini, Lauren A
- Taylor, Allen J
- Weigold, William Guy
- Weissman, Gaby
- Younes, Desiree
Citation: - Jacc: Cardiovascular Imaging. 5(6):589-95, 2012 Jun.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department: - Medicine/General Internal Medicine
Medline publication type:
- Comparative Study
- Journal Article
All authors: - Ghafourian K, Simprini LA, Taylor AJ, Weigold WG, Weissman G, Younes D
|
|
|
5.
|
Ten-year weight gain is not associated with multiple cardiometabolic measures in Alaska EARTH study participants. MedStar authors:
- Howard, Barbara V
- Umans, Jason G
Year: 2021
Citation: - Nutrition Metabolism & Cardiovascular Diseases. 31(2):403-410, 2021 02 08.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Beans J, Day G, Hiratsuka VY, Holck P, Howard BV, Koller KR, Nash SH, Redwood D, Umans J
|
|
|
6.
|
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. MedStar authors:
Year: 2018
Citation: - The Lancet Diabetes & Endocrinology. 6(4):275-286, 2018 04.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Andreassen C, Aroda VR, Lingvay I, Ludemann J, Navarria A, Pratley RE, SUSTAIN 7 investigators, Viljoen A
|
|
|
7.
|
|
|
|
8.
|
Cardiometabolic Syndrome in People With Spinal Cord Injury/Disease: Guideline-Derived and Nonguideline Risk Components in a Pooled Sample. MedStar authors:
- Groah, Suzanne L
- Ljungberg, Inger H
- Tinsley, Emily A
Year: 2016
Citation: - Archives of Physical Medicine & Rehabilitation. 97(10):1696-705, 2016 Oct
Institution:
- MedStar National Rehabilitation Network
- MedStar Washington Hospital Center
Department: - Physical Medicine and Rehabilitation
Medline publication type:
All authors: - Betancourt LF, Burns-Drecq PA, David M, Groah SL, Ljungberg IH, Mendez AJ, Nash MS, Tinsley EA, Tractenberg RE
|
|
|
9.
|
Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program. MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(10):2738-45, 2014 Oct.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Observational Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Aroda VR, Bray GA, Delahanty LM, Diabetes Prevention Program Research Group, Florez JC, Franks PW, Jablonski KA, Kahn SE, Pan Q, Perreault L, Watson KE
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial. MedStar authors:
Year: 2016
Citation: - Diabetes Care. 39(9):1579-86, 2016 Sep
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Diamant M, Fonseca V, LixiLan PoC Study Group, Perfetti R, Rosenstock J, Silvestre L, Souhami E, Zhou T
|
|
|
13.
|
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial. MedStar authors:
Year: 2019
Citation: - Diabetes Care. 42(12):2262-2271, 2019 12.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Araki E, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, PIONEER 8 investigators, Tarp-Johansen MJ, Zinman B
|
|
|
14.
|
Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) versus insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. MedStar authors:
Year: 2017
Citation: - Diabetes, Obesity & Metabolism. 19(10):1408-1415, 2017 Oct.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Bergenstal RM, Bonadonna RC, Kapitza C, LixiLan-L trial investigators, Niemoeller E, Puig-Domingo M, Souhami E, Stager W, Wysham C, Yu C
|
|
|
15.
|
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. MedStar authors:
Year: 2016
Citation: - Diabetes Care. 39(11):1972-1980, 2016 Nov
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Bellido D, Bergenstal RM, Gonzalez-Galvez G, Guo H, LixiLan-L Trial Investigators, Niemoeller E, Rosenstock J, Souhami E, Takami A, Unger J, Wysham C
|
|
|
16.
|
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial. MedStar authors:
Year: 2018
Citation: - Diabetes Care. 41(2):258-266, 2018 02.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Ahmann AJ, Annett MP, Aroda VR, Capehorn M, Charpentier G, Dotta F, Henkel E, Holst AG, Lingvay I
|
|
|
17.
|
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. MedStar authors:
Year: 2020
Citation: - Diabetes Care. 43(5):940-947, 2020 05.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Butera NM, Camp AW, Cherrington A, Craig J, Fortmann SP, GRADE Research Group, Hollander PA, Krakoff J, Perez M, Phillips LS, Rasouli N, Sivitz WI, Tan MH, Tiktin M, Wexler DJ, Younes N
|
